CTNM - Company ID 0001855175
The table below shows Contineum Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $75.20M | $14.71M | $20.16M | $42.63M | $20.78M | $22.47M |
| Short-term investments | $169.29M | $221.84M | $226.17M | $139.77M | $154.70M | $168.24M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $249.74M |
| $242.58M |
| $252.96M |
| $184.93M |
| $176.84M |
| $192.13M |
| Property, plant & equipment | $848.00K | $929.00K | $1.06M | $880.00K | $856.00K | $891.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $256.99M | $250.37M | $261.35M | $190.85M | $182.89M | $198.26M |
| Accounts payable | $641.00K | $505.00K | $1.50M | $786.00K | $2.00M | $3.65M |
| Total current liabilities | $8.03M | $6.53M | $6.66M | $6.36M | $7.21M | $8.95M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $11.57M | $10.71M | $11.31M | $10.38M | $11.50M | $13.50M |
| Retained earnings | -$225.69M | -$206.99M | -$191.84M | -$162.22M | -$149.43M | -$133.39M |
| Total equity | $245.42M | $239.66M | $250.04M | $180.47M | $171.39M | $184.77M |